WUHAN GENERAL GROUP

M2bio Sciences Inc. formerly Wuhan General Group, Inc. is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research that develops and commercializes a range of CBD and mushrooms based products under Dr. AnnaRx™, Medspresso™ and Handcrafted Delights™ brands. In addition, our research and clinical trials with psilocybin are aimed for new therapies that will help patients who suffer from alcohol addiction, mental illness and heart diseases.

WUHAN GENERAL GROUP

Social Links:

Facebook

Twitter

Industry:

Biotechnology Cannabis Health Care Medical

Founded:

1988-07-19

Address:

Cape Town, NA - South Africa, South Africa

Country:

South Africa

Website Url:

http://www.m2bio.co

Total Employee:

Status:

Active

Email Addresses:

[email protected]

Total Funding:

450 K USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Amazon US Privacy User Signal Mechanism PHP 7 CloudFront Pound Sterling OpenResty

Similar Organizations

arima-genomics-logo

Current Employees Featured

not_available_image

Michael Sachar
Michael Sachar CEO @ Wuhan General Group
CEO
2021-06-01

Founder

not_available_image

Anna Morera Leralta

jeff-robinson_image

Jeff Robinson

not_available_image

Ramy Kamaneh

Stock Details

Company's stock symbol is OTCPINK:WUHN

Acquisitions List

Date	Company	Article	Price
2019-01-01	MJ MedTech	MJ MedTech acquired by Wuhan General Group	N/A

Investors List

threed-capital-inc_image

ThreeD Capital

ThreeD Capital investment in Post-IPO Equity - Wuhan General Group

Key Employee Changes

Date	New article
2021-05-20	Wuhan General Group Appoints Michael Sachar CEO of M2Bio Sciences Food & Beverage

Official Site Inspections

http://www.m2bio.co Semrush global rank: 7.28 M Semrush visits lastest month: 543

Host Informations
Whois Informations

Loading ...